To restrict access to therapy with KYNAMRO to patients with a clinical or laboratorydiagnosis consistent with homozygous familial hypercholesterolemia (HoFH).
Public Health Wales said on Friday that laboratory tests confirmed a diagnosis of measles but further tests were needed to determine the cause of death.
Reams of research point to the same finding: physicians looking at the same thing will disagree with each other, or even with themselves, from 10 percent to 50 percent of the time during virtually every aspect of the medical-care process from taking a medical history to doing a physical examination, reading a laboratory test, performing a pathological diagnosis and recommending a treatment.